Biomea Fusion (BMEA) Net Income towards Common Stockholders (2020 - 2026)
Biomea Fusion's (BMEA) quarterly Net Income towards Common Stockholders came in at -$12.4 million in Q2 2026, up 40.64% year-over-year from -$8.9 million in Q2 2025, and down 0.83% quarter-over-quarter from -$12.3 million in Q1 2026.
Biomea Fusion (BMEA) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Biomea Fusion has disclosed Net Income towards Common Stockholders across 7 years of filings, most recently posting -$12.4 million for Q2 2026.
- In Q2 2026, Net Income towards Common Stockholders rose 40.64% year-over-year to -$12.4 million; the TTM figure through Jun 2026 stood at -$56.4 million (up 49.75% YoY), while the FY2025 annual figure was -$81.7 million, up 41.01% from the prior year.
- Net Income towards Common Stockholders came in at -$12.4 million for Q2 2026 at Biomea Fusion, down from -$12.3 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$12.3 million in Q1 2026 to a low of -$39.1 million in Q1 2024.
- Average Net Income towards Common Stockholders over 5 years is -$24.7 million, with a median of -$25.1 million recorded in 2022.
- Year-over-year, Net Income towards Common Stockholders tumbled 179.67% in 2022 and jumped 57.82% in 2026.
- Over 5 years, Net Income towards Common Stockholders stood at -$25.3 million in 2022, then slumped by 37.81% to -$34.9 million in 2023, then climbed by 16.0% to -$29.3 million in 2024, then soared by 47.97% to -$15.2 million in 2025, then rose by 18.35% to -$12.4 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$12.4 million in Q2 2026, -$12.3 million in Q1 2026, and -$15.2 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | -238.00 Mn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 3.32 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 398.69 Mn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | -644.37 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 237.01 Mn |
| 10 | Biomea Fusion | 132.65 Mn | 132.65 Mn | - | -12.45 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.45 Mn |
| Mar 31, 2026 | -12.34 Mn |
| Dec 31, 2025 | -15.25 Mn |
| Sep 30, 2025 | -16.41 Mn |
| Jun 30, 2025 | -20.97 Mn |
| Mar 31, 2025 | -29.26 Mn |
| Dec 31, 2024 | -29.30 Mn |
| Sep 30, 2024 | -32.79 Mn |
| Jun 30, 2024 | -37.28 Mn |
| Mar 31, 2024 | -39.06 Mn |
| Dec 31, 2023 | -34.88 Mn |
| Sep 30, 2023 | -28.43 Mn |
| Jun 30, 2023 | -24.89 Mn |
| Mar 31, 2023 | -29.05 Mn |
| Dec 31, 2022 | -25.31 Mn |
| Sep 30, 2022 | -22.89 Mn |
| Jun 30, 2022 | -17.26 Mn |
| Mar 31, 2022 | -16.37 Mn |
| Dec 31, 2021 | -14.71 Mn |
| Sep 30, 2021 | -12.61 Mn |
Biomea Fusion Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=BMEA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "BMEA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=BMEA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();